Precigen, Inc.

20374 Seneca Meadows Pkwy
Germantown, MD, 20876-7004  United States
(301) 556-9900
Company Type: Corporation Parent

One man's frankenfood is another man's solution to world hunger. Intrexon is developing technology that uses synthetic biology, or biological engineering, to make advances in everything from pharmaceuticals to genetically modified plants and animals. The company has development agreements with AmpliPhi (antibacterial medication), AquaBounty (genetically modified salmon), BioLife (genetic disease), Eli Lilly (animal medication), Fibrocell (dermatology medication), Genopaver (pharmaceutical ingredients), Oragenics (antibiotics), Soligenix (antibiotics), Synthetic Biologics (antibiotics), and ZIOPHARM (cancer medicine). Intrexon went public in 2013, raising $160 million in its IPO.

Try D&B Hoovers Free

Financial Statements

Financial data as of December 31, 2019 (12 month period) in USD

Annual Revenue 2019
$90.72 millionUSD

Dun & Bradstreet collects private company financials for more than 23 million companies in over 200 countries. Find out more.

Company Snapshot

Essential information for a successful call

  •  EMPLOYEES (This Site) 9
  •  EMPLOYEES (All Sites) 979
  • ASSETS (MIL USD) 456
  •  SALES (MIL USD) 90.72
  • TICKER SYMBOL PGEN
  • Incorporated 1998
  • FISCAL YEAR END DEC

Get in Touch with 3 Contacts

A D&B Hoovers Subscription is your foot in the door to Precigen, Inc. contact information.
  • Helen Sabzevari
    President and Chief Executive Officer
  • RANDAL KIRK
    Chairman of the Board
  • THOMAS P BOSTICK
    Chief Operating Officer
  • RICK STERLING
    Chief Financial Officer
See full contact details
Start Your Free Trial

Get full access to D&B Hoovers

With a Hoovers subscription you can get a comprehensive view of Precigen, Inc.

Precigen, Inc.

3
Contacts
Reach the right people with access to detailed contact information.
35
Corporate Relations
Get the big picture on a company's affiliates and who they do business with.
9
Close Industry Peers
See similar companies for insight and prospecting.